scholarly journals Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting

2013 ◽  
pp. 493 ◽  
Author(s):  
Frederik Hvid-Jensen ◽  
Lars Pedersen ◽  
Rikke Nielsen ◽  
Peter Funch-Jensen ◽  
Asbjørn Mohr Drewes ◽  
...  
2016 ◽  
Vol 64 (3) ◽  
pp. 361-363 ◽  
Author(s):  
Pepijn Huizinga ◽  
Marjolein Kluytmans– van den Bergh ◽  
Miranda van Rijen ◽  
Ina Willemsen ◽  
Nils van ‘t Veer ◽  
...  

2014 ◽  
Vol 68 (11) ◽  
pp. 1352-1357 ◽  
Author(s):  
G. Lindner ◽  
G.-C. Funk ◽  
A. B. Leichtle ◽  
G. M. Fiedler ◽  
C. Schwarz ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (7) ◽  
pp. e100235 ◽  
Author(s):  
Maija E. Miettinen ◽  
Leena Kinnunen ◽  
Jaana Leiviskä ◽  
Sirkka Keinänen-Kiukaanniemi ◽  
Eeva Korpi-Hyövälti ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (11) ◽  
pp. e0143656 ◽  
Author(s):  
Akio Nakashima ◽  
Ichiro Ohkido ◽  
Keitaro Yokoyama ◽  
Aki Mafune ◽  
Mitsuyoshi Urashima ◽  
...  

2019 ◽  
Vol 6 (3) ◽  
pp. 105-113 ◽  
Author(s):  
Ivanka Hendrix ◽  
Amy T. Page ◽  
Maarit J. Korhonen ◽  
J. Simon Bell ◽  
Edwin C. K. Tan ◽  
...  

BMJ Open ◽  
2019 ◽  
Vol 9 (10) ◽  
pp. e030780
Author(s):  
Kristina Laugesen ◽  
Irene Petersen ◽  
Lars Pedersen ◽  
Finn Breinholt Larsen ◽  
Jens Otto Lunde Jørgensen ◽  
...  

ObjectivesLifestyle may affect observed associations between glucocorticoid use and adverse events. This study aimed to investigate whether lifestyle differ according to use of systemic glucocorticoids.DesignPopulation-based cross-sectional study.SettingThe Central Denmark Region.Participants30 245 adults (≥25 years of age) who participated in a questionnaire-based public health survey in 2010.Outcome measuresSystemic glucocorticoid use was categorised as never use, current use (prescription redemption ≤90 days before completing the questionnaire), recent use (prescription redemption 91–365 days before completing the questionnaire), former use (prescription redemption >365 days before completing the questionnaire) and according to cumulative dose expressed in prednisolone equivalents (<100, 100–499, 500–999, 1000–1999, 2000–4999, ≥5000 mg). We computed the prevalence of lifestyle factors (body mass index, smoking, alcohol intake, physical activity and dietary habits) according to glucocorticoid use. We then estimated age-adjusted prevalence ratios (aPRs) and 95% CIs, comparing the categories of glucocorticoid users versus never users. All analyses were stratified by sex.ResultsOf the 30 245 participants (53% women, median age 53 years), 563 (1.9%) were current users, 885 (2.9%) were recent users, 3054 (10%) were former users and 25 743 (85%) were never users. Ever users of glucocorticoids had a slightly higher prevalence of obesity than never users (18% vs 14%, aPR=1.4, 95% CI 1.2 to 1.5 in women and 17% vs 15%, aPR=1.2, 95% CI 1.1 to 1.4 in men). In women, ever users of glucocorticoids had a slightly lower prevalence of high-risk alcohol consumption compared with never users (17% vs 20%, aPR=0.8, 95% CI 0.7 to 1.0). Smoking, diet and physical activity did not differ substantially according to use of glucocorticoids.ConclusionOur study provides a framework for quantifying potential uncontrolled confounding by lifestyle factors in studies of systemic glucocorticoids.


Sign in / Sign up

Export Citation Format

Share Document